Alopecia areata
MONDO:0005340Loss of scalp and body hair involving microscopically inflammatory patchy areas.
Also known as: alopecia areata, alopecia circumscripta, patchy loss of hair
64 clinical trials for this condition and its sub-types.
Follow this condition — get notified about new trialsSub-types
Broader categories
-
Hair loss showdown: can a chemo drug gel beat minoxidil for alopecia areata?
Disease control Not yet recruitingThis study tests whether a gel containing methotrexate, an immune-suppressing drug, can regrow hair in people with localized alopecia areata better than minoxidil spray. About 268 adults with less than 25% scalp hair loss will apply one of the two treatments twice daily for 24 we…
Phase: PHASE4 • Sponsor: Jinnah Postgraduate Medical Centre • Aim: Disease control
Last updated Jun 27, 2026 11:00 UTC
-
New hope for hair loss: vitamin d cream vs steroid shots
Disease control Not yet recruitingThis study tests whether a vitamin D-based cream (calcipotriol) works as well as steroid injections for regrowing hair in people with patchy alopecia areata. Sixty adults with less than half their scalp affected will use one of the two treatments for 12 weeks. The goal is to see …
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated Jun 27, 2026 09:10 UTC
-
Hair loss drug showdown: tofacitinib vs methotrexate in new trial
Disease control Not yet recruitingThis study compares two oral medications—tofacitinib and methotrexate—for treating severe alopecia areata, an autoimmune condition causing hair loss. 78 adults aged 18-60 with severe scalp or total body hair loss will take one of the drugs for 12 weeks. The main goal is to see wh…
Phase: PHASE4 • Sponsor: Hayat Abad Medical Complex, Peshawar • Aim: Disease control
Last updated Jun 27, 2026 09:04 UTC
-
Italian skin disease registry aims to map treatment journeys for 20,000 patients
Knowledge-focused Not yet recruitingThis study will collect existing medical records from about 20,000 people aged 12 and older in Italy who have one of five inflammatory skin conditions: psoriasis, atopic dermatitis, vitiligo, alopecia areata, or hidradenitis suppurativa. Researchers want to describe who gets thes…
Sponsor: Fondazione ISIDE • Aim: Knowledge-focused
Last updated Jun 27, 2026 08:11 UTC